Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.

Ferreira I, Croca S, Raimondo MG, Matharu M, Miller S, Giles I, Isenberg D, Ioannou Y, Hanly JG, Urowitz MB, Anderson N, Aranow C, Askanase A, Bae SC, Bernatsky S, Bruce IN, Buyon J, Clarke AE, Dooley MA, Fortin P, Ginzler E, Gladman D, Gordon C, Inanc M, Jacobsen S, Kalunian K, Kamen D, Khamashta M, Lim S, Manzi S, Merrill J, Nived O, Peschken C, Petri M, Ramsey-Goldman R, Ruiz-Irastorza G, Sanchez-Guerrero J, Steinson K, Sturfelt GK, van Vollenhoven R, Wallace DJ, Zoma A, Rahman A.

Arthritis Res Ther. 2017 Dec 22;19(1):287. doi: 10.1186/s13075-017-1495-6.

2.

Atherosclerosis in systemic lupus erythematosus.

Croca S, Rahman A.

Best Pract Res Clin Rheumatol. 2017 Jun;31(3):364-372. doi: 10.1016/j.berh.2017.09.012. Epub 2017 Oct 16. Review.

PMID:
29224678
3.

Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque.

Smith E, Croca S, Waddington KE, Sofat R, Griffin M, Nicolaides A, Isenberg DA, Torra IP, Rahman A, Jury EC.

Sci Immunol. 2016 Dec 2;1(6). pii: eaah4081. doi: 10.1126/sciimmunol.aah4081.

PMID:
28783690
4.

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study.

Croca S, Bassett P, Chambers S, Davari M, Alber KF, Leach O, Ioannou Y, Giles I, Isenberg D, Rahman A.

Arthritis Res Ther. 2015 Feb 9;17:26. doi: 10.1186/s13075-015-0539-z.

5.

Long-term activity index after renal failure in a cohort of 32 patients with lupus nephritis.

González-Pulido C, Croca S, Abrol E, Isenberg DA.

Clin Exp Rheumatol. 2014 May-Jun;32(3):301-7. Epub 2014 Apr 7.

PMID:
24708901
6.

Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study.

Croca S, Bassett P, Pericleous C, Alber KF, Latchman D, Isenberg D, Giles I, Rahman A, Ioannou Y.

Arthritis Res Ther. 2014 Feb 7;16(1):R48. doi: 10.1186/ar4477.

7.

Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus.

Reddy V, Croca S, Gerona D, De La Torre I, Isenberg D, McDonald V, Leandro M, Cambridge G.

Rheumatology (Oxford). 2013 May;52(5):951-2. doi: 10.1093/rheumatology/ket004. Epub 2013 Feb 18. No abstract available.

PMID:
23424262
8.

Imaging assessment of cardiovascular disease in systemic lupus erythematosus.

Croca SC, Rahman A.

Clin Dev Immunol. 2012;2012:694143. doi: 10.1155/2012/694143. Epub 2011 Oct 23. Review.

9.

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.

Díaz-Lagares C, Croca S, Sangle S, Vital EM, Catapano F, Martínez-Berriotxoa A, García-Hernández F, Callejas-Rubio JL, Rascón J, D'Cruz D, Jayne D, Ruiz-Irastorza G, Emery P, Isenberg D, Ramos-Casals M, Khamashta MA; UK-BIOGEAS Registry.

Autoimmun Rev. 2012 Mar;11(5):357-64. doi: 10.1016/j.autrev.2011.10.009. Epub 2011 Oct 18.

PMID:
22032879
10.

Assessment of a lupus nephritis cohort over a 30-year period.

Croca SC, Rodrigues T, Isenberg DA.

Rheumatology (Oxford). 2011 Aug;50(8):1424-30. doi: 10.1093/rheumatology/ker101. Epub 2011 Mar 16.

PMID:
21415024

Supplemental Content

Support Center